Market Data
News
Tools
Markets
Discover
Subscribe Login/Register
S&P ASX 200
7,158.10
(
0.67%
)
S&P ASX All Technology
2,418.70
(
1.18%
)
Brent Oil
74.355
(
0.04%
)
US Dollar vs AUD
1.51893
(
-0.09%
)
Bitcoin
26,835.30
(
0.05%
)
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Xeris Biopharma Holdings Inc (XERS)

  7. Xeris Biopharma Holdings Inc (XERS) Financials

XERS

Xeris Biopharma Holdings Inc

2.62
0.06 (2.34%)
Upgrade to Real-Time

Xeris Biopharma Holdings Inc. (XERS) Fundamentals
SHARE INFORMATION
Market CapUS$ 359,756,046
Shares Outstanding137,311,468
Float122,828,787
Percent Float89.45%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 110,248,000
Latest Fiscal EPSUS$ -0.70
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions222
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months2,598,124
Institutional Holdings Percent62.5%
Institutional Sold Previous 3 Months2,541,842
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months2,935,000
Insider Holdings Percent5.5
Insider Sold Previous 3 Months-
Insider Shares Owned7,574,712
TRADING INFO
52 Week HighUS$ 3.03
52 Week LowUS$ 0.97
52 Week High ChangeUS$ 20.74
21 Day Moving AverageUS$ 2.7114
21 Day Extended Moving AverageUS$ 2.6412
50 Day Moving AverageUS$ 2.2602
50 Day Extended Moving AverageUS$ 2.3279
200 Day Moving AverageUS$ 1.6246
200 Day Extended Moving AverageUS$ 1.8514
10 Day Average Volume949,102
20 Day Average Volume1,321,781
30 Day Average Volume1,245,058
50 Day Average Volume1,334,570
Alpha-0.015153
Beta1.3336
Standard Deviation0.253722
R20.081179
7 Day Price ChangeUS$ -0.22
7 Day Percent Change-7.75%
21 Day Price ChangeUS$ -0.30
21 Day Percent Change-10.27%
30 Day Price ChangeUS$ 0.18
30 Day Percent Change7.38%
Month to Date Price ChangeUS$ 0.06
Month to Date Percent Change2.34%
Quarter to Date Price ChangeUS$ 0.99
Quarter to Date Percent Change60.74%
180 Day Price ChangeUS$ 1.07
180 Day Percent Change69.03%
200 Day Price ChangeUS$ 1.14
200 Day Percent Change77.03%
Year to Date Price ChangeUS$ 1.29
Year to Date Percent Change96.99%

Xeris Biopharma Holdings Inc. (XERS) Key Ratios

PROFITABILITY
EBIT Margin-73.3%
EBITDA Margin-61.8%
Pre-Tax Profit Margin-267.7%
Profit Margin Count-0.51%
Gross Margin79.5%
Profit Margin TOT-0.51%
INCOME STATEMENTS
RevenueUS$ 88,175,000
Revenue Per ShareUS$ 0.6422
Revenue (3 Years)US$ 243.42
Revenue (5 Years)US$ 134.46
FINANCIAL STRENGTH
Price to Tangible Book-1.70
Total Debt To Equity4.40
Int Coverage0.00
Current Ratio2.50
Leverage Ratio7.60
Quick Ratio2.10
Long Term Debt To Capital0.81
VALUATION MEASURES
PE Ratio0.00
Enterprise ValueUS$ 456,205,473
Price to Sales1.53
Price to Free Cash0.00
PE High Last 5 Years0.00
Price To Book3.70
Price To Cash Flow-2.60
PE Low Last 5 Years-7.70
Price to Tangible Book-1.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover4.60
Invoice Turnover1.10
Assets Turnover0.30
Return Assets-29.18
Return on Equity-134.83
Return on Capital-37.32

Xeris Biopharma Holdings Inc. (XERS) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
Auditornan
CEOPaul R. Edick
Employees-
Last Audit-
CIK0001346302
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address
Suite 1600
,
Website
Facsimile-
Telephone-
Email-
Your Recent History
NASDAQ
XERS
Xeris Biop..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: au D: 20230602 01:45:34